IBDEI1BS ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,23773,1,5,0)
 ;;=5^Metatarsal deformity; Acquired
 ;;^UTILITY(U,$J,358.3,23773,2)
 ;;=^123805
 ;;^UTILITY(U,$J,358.3,23774,0)
 ;;=754.70^^141^1469^4
 ;;^UTILITY(U,$J,358.3,23774,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23774,1,3,0)
 ;;=3^754.70
 ;;^UTILITY(U,$J,358.3,23774,1,5,0)
 ;;=5^Metatarsal deformity; Congenital
 ;;^UTILITY(U,$J,358.3,23774,2)
 ;;=^25440
 ;;^UTILITY(U,$J,358.3,23775,0)
 ;;=726.70^^141^1469^5
 ;;^UTILITY(U,$J,358.3,23775,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23775,1,3,0)
 ;;=3^726.70
 ;;^UTILITY(U,$J,358.3,23775,1,5,0)
 ;;=5^Metatarsalgia
 ;;^UTILITY(U,$J,358.3,23775,2)
 ;;=^272548
 ;;^UTILITY(U,$J,358.3,23776,0)
 ;;=355.6^^141^1469^10
 ;;^UTILITY(U,$J,358.3,23776,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23776,1,3,0)
 ;;=3^355.6
 ;;^UTILITY(U,$J,358.3,23776,1,5,0)
 ;;=5^Morton's metatarsalgia, neuralgia, or neuroma
 ;;^UTILITY(U,$J,358.3,23776,2)
 ;;=               ^268517
 ;;^UTILITY(U,$J,358.3,23777,0)
 ;;=736.79^^141^1469^7
 ;;^UTILITY(U,$J,358.3,23777,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23777,1,3,0)
 ;;=3^736.79
 ;;^UTILITY(U,$J,358.3,23777,1,5,0)
 ;;=5^Metatarsal adductus/varus; Acquired
 ;;^UTILITY(U,$J,358.3,23777,2)
 ;;=^272742
 ;;^UTILITY(U,$J,358.3,23778,0)
 ;;=754.53^^141^1469^8
 ;;^UTILITY(U,$J,358.3,23778,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23778,1,3,0)
 ;;=3^754.53
 ;;^UTILITY(U,$J,358.3,23778,1,5,0)
 ;;=5^Metatarsal adductus/varus; Congenital
 ;;^UTILITY(U,$J,358.3,23778,2)
 ;;=^273007
 ;;^UTILITY(U,$J,358.3,23779,0)
 ;;=355.8^^141^1469^9
 ;;^UTILITY(U,$J,358.3,23779,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23779,1,3,0)
 ;;=3^355.8
 ;;^UTILITY(U,$J,358.3,23779,1,5,0)
 ;;=5^Mononeuritis of lower limb, unspecified
 ;;^UTILITY(U,$J,358.3,23779,2)
 ;;=^268511
 ;;^UTILITY(U,$J,358.3,23780,0)
 ;;=729.1^^141^1469^11
 ;;^UTILITY(U,$J,358.3,23780,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23780,1,3,0)
 ;;=3^729.1
 ;;^UTILITY(U,$J,358.3,23780,1,5,0)
 ;;=5^Myalgia and myositis, unspecified
 ;;^UTILITY(U,$J,358.3,23780,2)
 ;;=^80160
 ;;^UTILITY(U,$J,358.3,23781,0)
 ;;=355.71^^141^1470^4
 ;;^UTILITY(U,$J,358.3,23781,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23781,1,3,0)
 ;;=3^355.71
 ;;^UTILITY(U,$J,358.3,23781,1,5,0)
 ;;=5^Nerve entrapment, lower limb
 ;;^UTILITY(U,$J,358.3,23781,2)
 ;;=^295729
 ;;^UTILITY(U,$J,358.3,23782,0)
 ;;=216.7^^141^1470^2
 ;;^UTILITY(U,$J,358.3,23782,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23782,1,3,0)
 ;;=3^216.7
 ;;^UTILITY(U,$J,358.3,23782,1,5,0)
 ;;=5^Neoplasm, skin of lower limb, including hip; Benign
 ;;^UTILITY(U,$J,358.3,23782,2)
 ;;=^267636
 ;;^UTILITY(U,$J,358.3,23783,0)
 ;;=239.2^^141^1470^3
 ;;^UTILITY(U,$J,358.3,23783,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23783,1,3,0)
 ;;=3^239.2
 ;;^UTILITY(U,$J,358.3,23783,1,5,0)
 ;;=5^Neoplasm, skin, bone and soft tissue; Unspecified
 ;;^UTILITY(U,$J,358.3,23783,2)
 ;;=^267783
 ;;^UTILITY(U,$J,358.3,23784,0)
 ;;=356.9^^141^1470^7
 ;;^UTILITY(U,$J,358.3,23784,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23784,1,3,0)
 ;;=3^356.9
 ;;^UTILITY(U,$J,358.3,23784,1,5,0)
 ;;=5^Neuropathy, peripheral, Hereditary; Unspecified
 ;;^UTILITY(U,$J,358.3,23784,2)
 ;;=^123931
 ;;^UTILITY(U,$J,358.3,23785,0)
 ;;=355.8^^141^1470^8
 ;;^UTILITY(U,$J,358.3,23785,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23785,1,3,0)
 ;;=3^355.8
 ;;^UTILITY(U,$J,358.3,23785,1,5,0)
 ;;=5^Neuropathy, peripheral, lower limb; Unspecified
 ;;^UTILITY(U,$J,358.3,23785,2)
 ;;=^268511
 ;;^UTILITY(U,$J,358.3,23786,0)
 ;;=356.2^^141^1470^5
 ;;^UTILITY(U,$J,358.3,23786,1,0)
 ;;=^358.31IA^5^2
